CIK 0001856725 · <br>Emerging growth company
Rani Therapeutics Holdings, Inc.
Sign in to watch- Ticker
- RANI
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 863114789
- Phone
- (408) 457-3700
- Business address
- 47709 FREMONT BLVD, FREMONT, CA, 94538
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 63 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-03-21 | Sanford Svai S Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +323,500 | 323,500 | ||
| 2023-12-16 | Groen Eric General Counsel | Returned to the company · Stock Option (Right to Buy) | −171,500 | 34,300 | ||
| 2023-12-16 | Groen Eric General Counsel | Grant or award · Stock Option (Right to Buy) | +171,500 | 171,500 | ||
| 2023-12-16 | Groen Eric General Counsel | Returned to the company · Stock Option (Right to Buy) | −43,400 | 31,000 | ||
| 2023-12-16 | Groen Eric General Counsel | Grant or award · Stock Option (Right to Buy) | +43,400 | 43,400 | ||
| 2023-12-16 | Groen Eric General Counsel | Returned to the company · Stock Option (Right to Buy) | −54,167 | 75,833 | ||
| 2023-12-16 | Groen Eric General Counsel | Grant or award · Stock Option (Right to Buy) | +54,167 | 54,167 | ||
| 2023-12-16 | McKinley Kate Chief Business Officer | Returned to the company · Stock Option (Right to Buy) | −250,000 | 0 | ||
| 2023-12-16 | McKinley Kate Chief Business Officer | Grant or award · Stock Option (Right to Buy) | +250,000 | 250,000 | ||
| 2023-12-16 | Sanford Svai S Chief Financial Officer | Returned to the company · Stock Option (Right to Buy) | −171,500 | 34,300 | ||
| 2023-12-16 | Sanford Svai S Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +171,500 | 171,500 | ||
| 2023-12-16 | Sanford Svai S Chief Financial Officer | Returned to the company · Stock Option (Right to Buy) | −58,334 | 41,666 | ||
| 2023-12-16 | Sanford Svai S Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +58,334 | 58,334 | ||
| 2023-12-16 | Sanford Svai S Chief Financial Officer | Returned to the company · Stock Option (Right to Buy) | −83,724 | 127,788 | ||
| 2023-12-16 | Sanford Svai S Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +83,724 | 83,724 | ||
| 2023-12-16 | Hashim Mir Chief Scientific Officer | Returned to the company · Stock Option (Right to Buy) | −171,500 | 34,300 | ||
| 2023-12-16 | Hashim Mir Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +171,500 | 171,500 | ||
| 2023-12-16 | Hashim Mir Chief Scientific Officer | Returned to the company · Stock Option (Right to Buy) | −73,150 | 52,250 | ||
| 2023-12-16 | Hashim Mir Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +73,150 | 73,150 | ||
| 2023-12-16 | Hashim Mir Chief Scientific Officer | Returned to the company · Stock Option (Right to Buy) | −83,724 | 127,788 |
Page 5 of 9 · 178 trades